Identification of a Potent and Selective 5-HT6 Antagonist:  One-Step Synthesis of (E)-3-(Benzenesulfonyl)-2- (methylsulfanyl)pyrido[1,2-a]pyrimidin- 4-ylidenamine …

YJ Wu, H He, S Hu, Y Huang, PM Scola… - Journal of medicinal …, 2003 - ACS Publications
Identification of a Potent and Selective 5-HT6 Antagonist: One-Step Synthesis of (E)-3-(Benzenesulfonyl)-2-
(methylsulfanyl)pyrido[1,2-a]pyrimidin- 4-ylidenamine from 2-(Benzenesulfonyl)-3,3- bis(methylsulfanyl)acrylonitrile …

Characterization of the aminomethylchroman derivative BAY× 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist

J De Vry, R Schohe-Loop, HG Heine, JM Greuel… - … of Pharmacology and …, 1998 - ASPET
The aminomethylchroman derivative BAY× 3702 (R-(−)-2-{4-[(chroman-2-ylmethyl)-amino]-
butyl}-1, 1-dioxo-benzo [d] isothiazolone hydrochloride) is a new high affinity 5 …

(+)-cis-4, 5, 7a, 8, 9, 10, 11, 11a-Octahydro-7H-10-methylindolo [1, 7-bc][2, 6]-naphthyridine: A 5-HT2C/2B Receptor Antagonist with Low 5-HT2A Receptor Affinity

J Nozulak, HO Kalkman, P Floerscheim… - Journal of medicinal …, 1995 - ACS Publications
The indolonaphthyridine 8 is described as a selective 5-HT2C/2B vs 5-HT2A receptor
antagonist. The compound was synthesized in seven steps starting from indolineand …

Hydroxy pentacyclic triterpene acid, kaempferol, inhibits the human 5-hydroxytryptamine type 3A receptor activity

S Lee, HS Seol, S Eom, J Lee, C Kim, JH Park… - International Journal of …, 2022 - mdpi.com
Monoamine serotonin is a major neurotransmitter that acts on a wide range of central
nervous system and peripheral nervous system functions and is known to have a role in …

Short and efficient syntheses of analogues of WAY-100635: new and potent 5-HT1A receptor antagonists

S Marchais, B Nowicki, H Wikström, LT Brennum… - Bioorganic & medicinal …, 2001 - Elsevier
Simple syntheses of four new and potent analogues of the 5-HT1A receptor ligand, WAY-
100635 are described, namely the 6-(pyridinyl)-bromo-, the 6-(pyridinyl)-fluoro-, the …

Synthesis of novel quinolone and quinoline-2-carboxylic acid (4-morpholin-4-yl-phenyl) amides: A late-stage diversification approach to potent 5HT1B antagonists

CL Horchler, JP McCauley Jr, JE Hall… - Bioorganic & Medicinal …, 2007 - Elsevier
Multiparallel amenable syntheses of 6-methoxy-8-amino-4-oxo-1, 4-dihydroquinoline-2-
carboxylic acid-(4-morpholin-4-yl-phenyl) amides (I) and 4-amino-6-methoxy-8-(4-methyl …

A novel class of 5-HT2A receptor antagonists: aryl aminoguanidines

HU Bryant, DL Nelson, D Button, HW Cole, MB Baez… - Life sciences, 1996 - Elsevier
Local delivery of serotonin (5-HT) produces a rapid edematous response in soft tissues via
increased fluid extravasation which is prevented by 5-HT2 antagonists such as ketanserin or …

5-HT3 receptors: role in disease and target of drugs

J Walstab, G Rappold, B Niesler - Pharmacology & therapeutics, 2010 - Elsevier
Serotonin type 3 (5-HT3) receptors are pentameric ion channels belonging to the
superfamily of Cys-loop receptors. Receptor activation either leads to fast excitatory …

DAU 6285: a novel antagonist at the putative 5-HT4 receptor

A Schiavone, E Giraldo, L Giudici, M Turconi… - Life sciences, 1992 - Elsevier
The antagonistic properties of DAU 6285, an azabicycloalkyl benzimidazolone derivative, at
putative 5-hydroxytryptamine 4 (5-HT 4) receptors were investigated in in vitro preparations …

Pharmacophore Directed Screening of Agonistic Natural Molecules Showing Affinity to 5HT2C Receptor

GK Veeramachaneni, VBSC Thunuguntla, M Bhaswant… - Biomolecules, 2019 - mdpi.com
Obesity prevalence continues to be a foremost health concern across the globe leading to
the development of major health risk conditions like type II diabetes, hyperlipidemia …